Banff Foundation for Allograft Pathology
Banff Foundation for Allograft Pathology
The Banff Foundation for Allograft Pathology is an organization dedicated to the advancement of knowledge and research in the field of allograft pathology, particularly in the context of organ transplantation. The foundation plays a pivotal role in the development and dissemination of standardized criteria for the diagnosis and classification of transplant rejection and other related conditions.
History[edit | edit source]
The Banff Foundation was established following the first Banff Conference on Allograft Pathology, which took place in Banff, Alberta, Canada, in 1991. The conference was organized by Dr. Kim Solez and brought together pathologists, transplant surgeons, and other specialists to address the need for standardized criteria in transplant pathology.
Banff Classification[edit | edit source]
The Banff Classification is a set of standardized criteria developed by the Banff Foundation for the diagnosis and classification of allograft rejection. It is widely used in the field of transplant pathology and has undergone several revisions since its inception. The classification system is based on histopathological findings and is used to guide clinical management of transplant recipients.
Revisions[edit | edit source]
The Banff Classification has been revised multiple times to incorporate new scientific findings and improve diagnostic accuracy. These revisions are typically discussed and agreed upon during the biennial Banff Conferences.
Banff Conferences[edit | edit source]
The Banff Conferences are biennial meetings organized by the Banff Foundation, where experts in the field of transplant pathology gather to discuss advancements, share research findings, and update the Banff Classification. These conferences serve as a platform for collaboration and innovation in the field.
Impact[edit | edit source]
The Banff Foundation has significantly impacted the field of transplant pathology by providing a standardized framework for diagnosing and classifying transplant rejection. This has improved the consistency and reliability of diagnoses across different institutions and has facilitated research and clinical trials in transplantation.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
